Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Clinical Study of Single Doses of JNJ-39439335 Versus Single and Multiple Doses of Naproxen Versus Placebo in the Treatment of Painful Osteoarthritis of the Knee: Focus on Treatment Effects and Methodological Advances.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Aug 2010
Price :
$35
*
At a glance
- Drugs Mavatrep (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 30 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2010 Planned end date changed from 1 May 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.